LOS ANGELES, June 13, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR IOVANCE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...

International Business Machines TodayIBMInternational Business Machines$278.37 -2.66 (-0.95%) 52-Week Range$167.23▼$283.06Dividend Yield2.41%P/E Ratio43.43Price Target$250.31Add to WatchlistMarkets have staged a fierce rally in the last month, led by typical tech giants like NVIDIA, Meta Platforms, Microsoft, and… wait, is that IBM’s music? Yes, International Business Machines Corp. NYSE: IBM has been one of the biggest winners lately and is riding a 10-day winning streak. However, this rally has actually ...

Key Takeaways ALL is benefiting from rising auto renewals, strong margins and a digital transformation strategy. BRK.B's insurance arm drives growth, backed by solid pricing, underwriting, and more than $100B in cash. ALL outperforms BRK.B on return on equity, despite higher debt and geographic concentration risk.Improved pricing, rising climate-related risks and rapid digitalization are poised to shape the insurance industry's trajectory in 2025. While insurers continue to face exposure to catastrophe lo ...

Key Takeaways TEM signed a $200M three-way deal with AZN and Pathos to build a multimodal oncology foundation model. The partnership lifts TEM's total remaining contract value to over $1B as of April 2025. TEM also expanded ties with ILMN to advance molecular profiling across all major disease areas.ForTempus AI (TEM) , expanding partnerships with existing customers across each of its product lines is key to its growth. In April 2025, the AI-driven precision medicine company extended its collaboration wit ...

Key Takeaways CALM's Q3 shell egg sales hit 331.4M dozen, up 10.2% year over year on strong seasonal demand. Year-to-date volume reached 971.2M dozen eggs, marking a 17% increase over the prior-year period. Capacity expansion and biosecurity efforts are expected to support continued production growth in 2025.Cal-Maine Foods, Inc. (CALM) , the largest producer and distributor of fresh shell eggs in the United States, sold a record 331.4 million dozen shell eggs in the third quarter of fiscal 2025 (ended Ma ...

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO” or the “Offering”), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the fir ...

LOS ANGELES, June 13, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YO ...

Key Takeaways PATH trades at a 4.37x forward P/S, below 5.68x of the industry average, suggesting relative undervaluation. Strong recurring revenues, global expansion and AI integrations support PATH's enterprise momentum. PATH's valuation trails peers like NOW and PEGA, despite faster growth and a focused automation strategy.UiPath Inc. (PATH) appears attractively valued compared with its industry peers based on the forward 12-month price-to-sales (P/S) ratio. Currently trading at 4.37x, PATH’s valuation ...

CHICAGO, June 13, 2025 /PRNewswire/ -- McDonald's USA, LLC and Entertainment Studios Network/The Weather Group today announced an agreement to settle pending litigation between them. The parties reached a confidential commercial agreement whereby McDonald's will continue to purchase advertising from ESN in a manner that aligns with its advertising strategy and commercial objectives and ESN will dismiss its lawsuit against McDonald's in the United States District Court for the Central District of California. ...

Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no add ...